Insufficient scRNA-seq data for expression of CHST10 at single-cell level.
Insufficient scRNA-seq data for expression of CHST10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2235.17 | 2642 / 2642 | 100% | 47.72 | 705 / 705 |
prostate | 100% | 889.18 | 244 / 245 | 100% | 17.87 | 501 / 502 |
thymus | 100% | 986.26 | 652 / 653 | 99% | 21.09 | 599 / 605 |
ovary | 100% | 1311.23 | 180 / 180 | 95% | 13.56 | 407 / 430 |
adrenal gland | 100% | 725.97 | 257 / 258 | 93% | 13.75 | 215 / 230 |
breast | 99% | 574.77 | 456 / 459 | 90% | 15.09 | 1011 / 1118 |
kidney | 97% | 476.13 | 86 / 89 | 80% | 8.45 | 720 / 901 |
skin | 73% | 409.81 | 1322 / 1809 | 98% | 22.73 | 464 / 472 |
lung | 90% | 581.06 | 522 / 578 | 74% | 10.25 | 855 / 1155 |
pancreas | 84% | 279.35 | 276 / 328 | 79% | 6.94 | 141 / 178 |
uterus | 99% | 1247.65 | 168 / 170 | 52% | 9.70 | 238 / 459 |
bladder | 100% | 721.05 | 21 / 21 | 44% | 4.84 | 224 / 504 |
esophagus | 82% | 607.69 | 1192 / 1445 | 37% | 3.54 | 68 / 183 |
stomach | 95% | 447.75 | 340 / 359 | 24% | 1.92 | 70 / 286 |
intestine | 82% | 563.51 | 791 / 966 | 19% | 1.43 | 99 / 527 |
eye | 0% | 0 | 0 / 0 | 100% | 23.50 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.68 | 29 / 29 |
spleen | 100% | 661.24 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.23 | 1 / 1 |
adipose | 99% | 522.73 | 1189 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 805.77 | 827 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 375.96 | 734 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 91% | 413.17 | 1216 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 7.80 | 27 / 45 |
peripheral blood | 29% | 195.13 | 272 / 929 | 0% | 0 | 0 / 0 |
liver | 2% | 5.11 | 4 / 226 | 23% | 2.06 | 94 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0007155 | Biological process | cell adhesion |
GO_0008209 | Biological process | androgen metabolic process |
GO_0007612 | Biological process | learning |
GO_0016051 | Biological process | carbohydrate biosynthetic process |
GO_0007616 | Biological process | long-term memory |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0016232 | Molecular function | HNK-1 sulfotransferase activity |
GO_0008146 | Molecular function | sulfotransferase activity |
Gene name | CHST10 |
Protein name | Carbohydrate sulfotransferase 10 Carbohydrate sulfotransferase (EC 2.8.2.-) Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST) (HuHNK-1ST) |
Synonyms | |
Description | FUNCTION: Catalyzes the transfer of sulfate from 3'-phosphoadenylyl sulfate (PAPS) to position 3 of terminal glucuronic acid of both protein- and lipid-linked oligosaccharides. Participates in biosynthesis of HNK-1 carbohydrate structure 3-O-sulfo-beta-D-GlcA-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc-R, a sulfated glucuronyl-lactosaminyl residue carried by many neural recognition molecules, which is involved in cell interactions during ontogenetic development and in synaptic plasticity in the adult. May be indirectly involved in synapse plasticity of the hippocampus, via its role in HNK-1 biosynthesis . Sulfates terminal glucuronyl residue of the laminin globular (LG)-domain binding epitope on DAG1/alpha-dystroglycan and prevents further polymerization by LARGE1 glycosyltransferase. Likely defines the chain length of LG epitope, conferring binding specificity to extracellular matrix components . Plays a role in down-regulating the steroid hormones. Sulfates glucuronidated estrogens and androgens with an impact in hormone cycle and fertility. Has a preference for glucuronyl moiety at the 3-hydroxyl group of a sterol ring rather than the 17-hydroxyl group, showing high catalytic efficiency for 17beta-estradiol 3-O-(beta-D-glucuronate) and dehydroepiandrosterone 3-O-(beta-D-glucuronate) hormones . . |
Accessions | C9JI33 ENST00000409046.5 ENST00000435960.5 ENST00000418201.5 C9JUE4 ENST00000420858.5 ENST00000409701.5 B8ZZ48 ENST00000264249.8 C9JCK7 C9J5X0 ENST00000421474.5 ENST00000448989.5 C9JWY0 O43529 |